SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " many " 4,946 found 🔀 AI-powered Shuffle
Germany news: Heat soars as political reforms split opinion
As Europe's heatwave rages, Germany continues to swelter with new records expected Saturday. Elsewhere, politicians bicker over reforms and industry blames train operator DB for billions in losses. DW has the latest.
Pro-Israel influencers criticize Vance, but evangelicals remain open to him
Despite attacks from some conservatives, a heavily pro-Israel crowd still has warm words for Vance, with many saying they could pick him as the party’s nominee.
Breakfast, lunch, dinner to hit 30g fiber goal: Nutrition scientist
You may eat fiber for gut health, but it plays many crucial roles in the body, from lowering cholesterol to helping to control glucose levels.
Satya Nadella said every company should build its own AI model
Satya Nadella said there should be "as many models in the world as firms in the world" and that reliance on a small set of models pose economic risks.
Businesses say NJ gridlock alerts near MetLife on World Cup match days is hurting them
Some are saying that boom never came and many say their business is going bust.
Good Sports: Former Bulldog track and field athlete aims to be flag football Olympian
Last June, Kaja Bins didn't know what flag football was. Kaja now has the potential to become an Olympian in a sport she learned a year ago.
‘Pineapple Days’ sidewalk sale draws business to Lincoln stores amid downtown construction
Cinnamon Dokken, owner of A Novel Idea Bookstore, said it was named for the Lemon Days sidewalk sales that many businesses around Lincoln used to do, instead using pineapples.
I Took My 12-Year-Old Dog to See 'Supergirl' and It Completely Changed the Movie for Me
Like many dog owners, I'm fully aware that my dog is the best dog. So when the chance to see the buzzy new 'Supergirl' with my 12-year-old Chihuahua-mix arose, I jumped at the opportunity.I was not prepared for how his presence would affect my review of the film.
The Best Last-Minute Prime Day Deals on Laptops, Monitors, and PC Accessories
Find deals on PC and Apple laptops, gaming and productivity monitors, and many PC accessories that will make your work life easier.
Paxton’s support for IVF highlights broader divide among GOP
Anti-abortion activists believe life begins at conception, so many oppose IVF because it often destroys some embryos.
Bunnie Xo says she told ‘so many girls’ to DM Jelly Roll amid divorce: 'Good luck with that'
Bunnie Xo said that she told 'so many girls' to DM Jelly Roll amid their divorce. The country star filed for divorce from the podcaster in May after nearly 10 years of marriage.
Air-conditioning becomes political amid sweltering Europe heatwave
Much of western Europe baked under a “heat dome” as temperatures soar. Authorities warn that the extreme conditions could endanger lives across countries, many of which have limited air conditioning, a topic of which has left the people of Paris divided.
Seattle ups its payout for vandalized small businesses. Is it enough?
For many businesses, the reimbursement "could be the difference between someone making their rent or not, just because this is such a tough time,” said Analog Coffee's owner.
Has VAR become a lottery at the World Cup?
After a week of strange decisions many supporters have been left scratching their heads with VAR.
Volkswagen reportedly planning to axe 100,000 jobs
Volkswagen, one of the world’s largest automakers, is reportedly planning to axe as many as 100,000 jobs over the next few years, representing 15% of its global workforce.
Sweden and WHO launch new long-term initiative to transform Ukraine’s health system
WHO and the Swedish International Development Cooperation Agency (Sida) have launched a new multi-year cooperation project to support the long-term recovery and transformation of Ukraine’s health system. The new project, “Ukraine’s Health System Transformation Initiative: Strengthening Health Governance, Health Financing and Service Delivery for Long-Term Recovery”, was launched at the Ukraine Recovery Conference 2026 in Gdansk, Poland on 26 June, and will run from June 2026 to 2029. Sweden will contribute approximately US$ 26 million (240 million Swedish krona) to support this project. This contribution forms part of Sweden’s broader support to Ukraine through the Team Europe approach, which brings together the European Union, its Member States, and key partners such as the European Commission’s Directorate-General for Enlargement and Eastern Neighbourhood and Enabel, and WHO as lead health agency, to support Ukraine’s recovery, reform agenda and European integration.“Ukraine’s health recovery cannot be measured only by what is rebuilt, but by whether people can count on the health system when they need it most. The scale of the task is immense, with health reconstruction and modernization needs estimated at US$ 19.4 billion over the next decade. Sweden’s US$ 26 million contribution to Ukraine’s Health System Transformation Initiative is a timely investment in the institutions, financing and services that will support Ukraine’s long-term recovery and European integration. WHO remains a trusted partner of the Government of Ukraine in advancing this process. I am deeply grateful to Sweden for its consistent support and partnership,” said Dr Hans Henri P. Kluge, WHO Regional Director for Europe. More than 4 years of war have placed unprecedented pressure on Ukraine’s health system, creating 3 interconnected challenges. The first is responding to the immediate consequences of the war and the urgent health needs of the population. The second is recovering and modernizing health services today. The third is continuing reforms and aligning the health system with European standards in the context of Ukraine’s future accession to the European Union. The war has led to large-scale population displacement, an increasing need for trauma care and rehabilitation, and shortages of health workers. High out-of-pocket payments in Ukraine make access to health services more difficult. Around 46% of total health expenditure is paid directly by individuals, placing a significant financial burden on many households and underscoring the need for reforms in health financing. Older people, persons with disabilities, women, children and veterans continue to face the greatest difficulties in accessing health services. “Ukraine is demonstrating that health system transformation can continue even during war. Ukraine is also continuing to align its health system with European norms and standards. WHO is committed to supporting Ukraine on this journey. We provide technical support, help coordinate partners’ efforts and support the institutional changes needed to strengthen the system. We are grateful to Sweden for its support. Through this partnership, we can help Ukraine build a more resilient, accessible and people-centred health system,” said Dr Jarno Habicht, WHO Representative in Ukraine. About the Health System Transformation InitiativeThe new initiative will support Ukraine through 3 interconnected areas: strengthening governance and coordination of health sector reforms through more inclusive coordination platforms and structured policy dialogue; transforming service delivery by reinforcing a primary health care-centred model that integrates family medicine, nursing and midwifery; and improving financial sustainability by supporting reforms that ensure the long-term viability of the national health system and reduce out-of-pocket payments for households. Overall, these reforms are expected to make the health system more coherent and easier to navigate, improve the quality and continuity of care, and ensure more equitable access to services, particularly for those who need them most. They will also support Ukraine’s progress towards a more modern health system aligned with European standards. “We are convinced that long-term recovery is not possible without strong, high-quality, person-centred health services that are accessible to everyone. Our partnership with WHO is designed to support deep and lasting systemic changes. Investments in human capital especially autonomous midwives, whose role for maternal, newborn and adolescent sexual and reproductive health cannot be understated, stronger governance, digital transformation and the financial sustainability of the health system are investments in Ukraine’s future. We are proud to support this process,” said Malin Perhult, the Head of the Ukraine Unit at Sida. Focus throughout implementation will be given to the most vulnerable population groups, including older people, women and children, and persons with disabilities, who have been affected by the war and face greater health-care needs. The initiative will be implemented in close cooperation with the Ministry of Health of Ukraine, the National Health Service of Ukraine, the Public Health Centre of Ukraine, regional authorities and international partners. This project will help Ukraine move towards a system where everyone can access the health care they need. It will strengthen primary care, make the health finance system more stable and predictable, and reduce the out-of-pocket costs that Ukrainians face when using health services. As a result, the Ukrainian health system will become more aligned with European standards and more sustainable in the long run.
Should “Success” in Science Be Measured Differently?
Publication volumes are one of the main ways that success is measured for researchers today. From mentorship to real-world impact, scientists argue that “publish or perish” pressures overlook many of the contributions that drive discovery forward.
Massachusetts marijuana legalization repeal question battle heats up
Cannabis industry leaders are urging businesses to take the initiative seriously after many previously dismissed its chances.
What could be next for Gakpo?
Following the departure of Mohamed Salah, at least one more attacking signing is expected at Anfield this summer. Liverpool have already signed Victor Munoz from Osasuna for £34.5m and the pursuit of Yan Diomande is heating up. Talented teenager Rio Ngumoha is also set to play a more prominent role, while Florian Wirtz played off the left for Liverpool at times last season and is featuring there for Germany in the World Cup.
Trump will present the World Cup trophy. It could be VERY awkward
The president has launched a war with nation in the tournament, and a war of words with many others.
Ecuador vs Germany Extended Highlights
Check out the full game highlights between Ecuador and Germany in the 2026 FIFA World Cup™. Announced by Ian Darke and Landon Donovan.
This autism therapy is covered by many insurers. Why does the military’s plan restrict it?
Logan Cabiao started applied behavior analysis therapy for autism when he was 2. Several years later, TRICARE, the military’s healthcare program, imposed major coverage restrictions.
Ecuador vs Germany Highlights
Check out the full game highlights between Ecuador and Germany in the 2026 FIFA World Cup™. Announced by Ian Darke and Landon Donovan.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
How many professional sports teams are in Austin?
With all the buzz around bringing more professional sports teams to the metro area, it’s worth considering how many are already here.
Ohio politicians respond to Supreme Court TPS ruling for Haitians and Syrians
The decision impacts more than 350,000 Haitians and 6,000 Syrians across the country, including many in Ohio.
Takeaways: Supreme Court hands Trump massive wins on immigration agenda
The Supreme Court’s conservative majority delivered President Donald Trump a pair of significant affirmations of his immigration policy Thursday, paving the way for the administration to effectively remove more than 1 million people from the US and keep many others from entering in the first place.
What to know about early warnings for earthquakes
Many countries have systems to alert people seconds before shaking begins in an earthquake. Experts say even a slight warning provides critical time for protection.
Merck KGaA to Acquire Bio-Techne for $11.3B, Expanding Life Science Tools Presence
Merck KGaA, Darmstadt, Germany, has agreed to acquire Bio-Techne for approximately $11.3 billion, the companies said today, in a deal designed to position the buyer as more of a leader across the life science value chain by expanding its presence in high-growth, next-generation life-sci markets with Bio-Techne’s tools, analytical technologies, and consumables.
The Supreme Court lets Trump deport people back to war zones
Trump’s administration may ignore procedural rules governing many of the most endangered people in America.
Check politics at the door? Not at many workplaces, researcher says
When people think of workplace segregation, they usually think of race or gender. Yet Americans are also sorted at work by something employers rarely measure: how they vote.
Federal judge halts Trump’s election executive order seeking to create a federal voter list
It was the second ruling in as many days against executive orders Trump has signed seeking oversight of the nation's elections.
Top Weekly Entertainment Picks
With America’s 250th Anniversary approaching, there are many star-spangled activities taking place in South Jersey, including a fireworks spectacular in
Semi-communal 'compound houses' in Ghana affect how people participate in political activity
Could the precise architectural form of your residence influence how much you participate in politics? A new study by MIT scholars finds this to be exactly the case—at least in Accra, Ghana, where many ...
Europe's heatwave shifts east as as France raises health alert to highest level
Temperatures in Germany could hit 40C in some areas while French officials say deaths linked to the heat are being seen among young people.
How to Watch the World Cup Today: Schedule, Times, TV, Streaming for USA, Germany, More
USA, Germany, Japan and more are in action today at the 2026 FIFA World Cup, with Groups D, E and F concluding on FOX and FS1.
Ensuring health for Special Olympics athletes
University of Minnesota healthcare students across many disciplines are helping to provide health screenings for athletes competing in the 2026 Special Olympics USA Games.
How should European scientists respond to the US AI kill switch?
Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.
Germany's Merck to buy Bio-Techne for $11.3 billion
Merck KGaA has agreed to acquire biotech firm Bio-Techne for $11.3 billion, the German science and healthcare firm said in a statement on Thursday.
Germany's Merck to buy Bio-Techne for $73 per share
Merck KGaA has agreed to acquire biotech firm Bio-Techne Corp for $73 per share in cash, the German science and healthcare firm said in a statement on Thursday.
Germany’s Merck to Buy Bio-Techne for $11 Billion
Merck KGaA offered $73 a share in cash to buy Bio-Techne, representing a 24% premium to the U.S. lab-tools supplier’s closing price Wednesday.
Commentary: Why Archie Bunker voters are disillusioned with U.S. politics
The 1970s “All in the Family” stalwart supported law-and-order, cultural conservatism and strong labor unions, values to which many Republicans have gravitated, while Democrats evolved into a constituency that adopted identity…
White House asks Congress for $88 billion for Iran war
The request mostly includes money for the Pentagon, with $67 billion going toward replenishing the military’s stocks of munitions and the cost of sending so many forces to the Middle East.
The biotech founder asking why good science gets stuck
As an undergraduate, Alinta Furnell led student societies, pitched startup ideas and built biotechnology ventures. Now, the UNSW alumna is investigating one of innovation’s biggest challenges – why so many scientific breakthroughs never make it beyond the lab.
World Cup crowds bring some boom, some bust for Seattle businesses
Ahead of Wednesday's World Cup match in Seattle, a clear pattern had emerged: Bars, cafés, and restaurants are surging with game-day energy, while many retail shops and businesses outside the immediate fan orbit are struggling to cash in.
The World Cup has been good for Johnson County, many businesses say
“We all have the same opportunities,” one business owner said. “There’s so many opportunities to go out and be proactive.”
Federal judge bars Trump from implementing proof of citizenship requirement to vote
The ruling by U.S. District Court Judge Denise Casper in Boston effectively converts a preliminary injunction she issued a year ago, in which she temporarily blocked many of Trump’s efforts to overhaul elections, into a permanent ban.
Dunnellon to mark America 250 with fireworks, entertainment
This year’s Fourth of July carries extra meaning for many citizens, as it represents the 250th anniversary of the signing of the Declaration of Independence. For the first time in
Gas prices, health, quality of life drive push for more Coloradans to trade four wheels for two, even if safety is a worry
Bike to Work Day brings out the cyclists in Denver, but many already pedal to their jobs and back.
Online violence against women in politics: what shapes political party responses to technology-facilitated gender-based violence?
Political parties have a primary role to play in tackling online violence against women and gender diverse politicians. While the prevalence and impact of TFGBV, such as coordinated disinformation campaigns, deepfake image-based sexual abuse or trolling are well documented, many parties are still building their knowledge on how to respond effectively and have not put in place internal practices and policies that respond to the rapidly evolving, poorly regulated digital ecosystem. About the ReportIn order to promote and protect fair and democratic participation in politics, this ALIGN Report explores what political parties are doing in response to TFGBV and what factors shape their action. The findings, based on existing literature and interviews with gender and politics professionals, indicate there are three sets of factors which donors, civil society and practitioners should consider when designing action to support political parties to respond to TFGBV internally. These are: (1) gender norms; (2) socio-political environment; and (3) internal party factors.Key messagesUnequal gender norms are ubiquitous across politics, shaping expectations of leaders to be strong and assertive, and practices of political parties to uphold masculinist values and sustain cultures of silence. These often lead to weak response to TFGBV against women politicians.The socio-political context can incentivise or disincentivise action, depending on the salience of gender issues, which are increasingly weaponised. Electoral competitiveness, domestic laws (i.e. quota requirements), and even the political system or global normative frameworks influence political will to act.Internal party factors that shape responses will vary across countries and contexts, but include: structures to enforce codes of conduct, policies and reporting mechanisms on (TF)GBV, political ideology, extent of centralisation of leadership, and crucially the meaningful participation of women in decision-making positions, not least through internal women’s wings.Party responses can be seen as a spectrum, with actions falling between active discouragement to address TFGBV to commitment to transform unequal norms and practices within the party.About the ToolkitTogether with the report, this ALIGN toolkit offers gender professionals and others working on democratic strengthening a set of guiding questions and reflection prompts to identify which responses could be most effective and suitable in different contexts. These actions can complement other solutions to TFGBV, such as regulations promoting safety by design. The assessment spans a broad range of factors including: (1) different manifestations of gender norms, (2) the socio-political environment and (3) internal party structures.Key messagesPolitical parties are duty-bound to take action internally to respond to the significant threats posed to women members and candidates, including from their own party colleagues, affiliates and political peers.Existing party approaches to TFGBV can be assessed along a spectrum which ranges from active discouragement and passive acceptance to minimal response and transformative change.To generate effective and context-appropriate solutions to TFGBV, it is important to consider how gender norms shape leadership expectations and internal party practices, while also analysing the impact of the socio-political environment. While actions to support women to stay safe online are very common, codes of conduct and measures to strengthen women’s voice and power in the parties are proposed as most transformative solutions.
'Voicemails for Isabelle' is Netflix's latest big hit — but viewers should expect tears
Zoey Deutch's Netflix rom-com has pleased both audiences and critics alike. But what viewers weren't expecting was how many tissues they would need while watching.
Startup’s strategy challenges EV industry assumptions
A new EV startup led by a former Amazon executive is betting that a low-cost, highly customizable pickup starting at just under $25,000 could help it achieve something that has eluded many EV startups: profitability, CNBC reports. The central goal for Slate Auto and CEO Peter Faricy is to make a full-size, practical truck accessible […]
As Ebola cases surge above 1,000, experts say outbreak could be worst ever
Insufficient contact-tracing and the refusal of many residents to avoid contact with the bodies of loved ones killed by the Ebola virus are accelerating the epidemic.
Morning sports: summer leagues starting
Jefferson Community college hosts many of the leagues.
The universe may be hiding conscious minds stranger than we can imagine
What if consciousness isn’t limited to brains like ours? Philosophers Eric Schwitzgebel and Jeremy Pober argue that consciousness could arise in many different forms of life, even in beings built from radically different materials than those found on Earth. Drawing on the vastness of the universe and the likely existence of countless alien civilizations, they suggest it would be surprisingly Earth-centric to assume that only Earth-like biology can support conscious experience.
Whole Health Institute looks to grow residencies
Many Arkansas-trained physicians leave the state for their residency, lowering the odds they return to practice here.
Fenway Sports Group wasn’t perfect, but it left the Penguins in a very good position
As the Penguins move into new hands, it's time to admit Fenway Sports Group was not the villain it was perceived by many to be.
Here are Hogsett’s top campaign donors. Many do business with the city
A first-time analysis of Hogsett’s campaign fundraising shows it's largely driven by law firms, engineering companies and other powerbrokers.
The $50B rural health transformation fund is pushing many hospitals to shrink
To avoid losing funding, many states are pursuing proven cost-saving models, such as downsizing inpatient care, rather than novel, untested approaches, some experts say.
German Business Outlook Improves Slightly as Uncertainty Wanes
Germany’s business outlook brightened slightly in June, easing worries about the knock-on effects of the Iran war on Europe’s largest economy.
KR Balance Patch
This article goes over the Korean June 2026 Balance Patch, including numerical changes to many classes and some reworks!
Why Combat Sports Continue to Attract Global Audiences
No sports experience can beat the adrenaline rush of witnessing two opponents battle each other on equal footing, armed only with skills, preparation, and sheer willpower. Throughout the ages, boxing, MMA, wrestling, and judo have continued entertaining people all over the globe, uniting fans from many different backgrounds with a common language. Discover how fascinating […] The post Why Combat Sports Continue to Attract Global Audiences appeared first on Native News Online.
The Caspian Sea Is Shrinking – And Humans Are The Problem
Dammed if you do: many countries have a huge incentive to fix the problem.
German business activity hits 18-month low in June, PMI shows
Germany's private sector activity contracted at its fastest pace in 18 months in June as the services downturn deepened, a survey showed on Tuesday.
German Business Activity Unexpectedly Worsens on Services Slump
Germany’s private sector shrank for a third month as sagging confidence over the Iran war sent services activity sinking at its fastest pace since 2022.
Little Saigon businesses say World Cup crowds downtown aren't boosting sales as hoped
But according to the organization, many business owners have reported fewer customers than expected during the tournament's opening weeks.
Ranking SEC recruiting classes via average commit distance
The 2027 recruiting cycle is moving at warp speed this summer. Prospects are making their college decisions in droves amidst official visit season. Dominoes are falling and classes are being built. Looking at the SEC, many programs are in states that are littered with blue-chip talent. You’ll often see the top schools go nationwide in […]
Why the forces that felled Keir Starmer threaten so many western leaders
British Prime Minister Keir Starmer was felled by a curse haunting most western leaders — a failure to deliver change to voters who’ve lost trust in the capacity of modern politics to make their lives better and more affordable.
The Best Prime Day Deals on AirPods, Apple Watch, AirTag, and More
Amazon Prime Day 2026 is here, and it will last for four days, ending this Friday, June 26. As it does every year, Prime Day offers shoppers a huge selection of deals across Amazon's storefront, and there are already many deals you can get on sale ahead of the event. Note: MacRumors is an affiliate partner with Amazon. When you click a link and make a purchase, we may receive a small payment, which helps us keep the site running.
Acer and ASUS resume PC shipments in Germany after Nokia HEVC patent dispute
Acer and ASUS are shipping affected notebooks and desktop PCs in Germany again, following months of restrictions linked to a Nokia video coding patent dispute.
Clive Davis, legendary music executive, dies at 94
Davis worked with Whitney Houston, Janis Joplin, and many others throughout his decades-long career.
Clive Davis, legendary music executive, dies at 94
Clive Davis, the legendary music executive who worked with Whitney Houston, Bruce Springsteen, and many others, has died at 94.
Can Canadian Organizations Deliver in the Next Era of Business AI? IBM Finds Many May Not Be Ready
As Canadian CEOs accelerate AI adoption to drive productivity and growth, C-suite leaders across Canada warn that governance, oversight and workforce readiness are struggling to keep pace, creating a widening 'control gap.'
Jewish voters express growing isolation amid rising antisemitism in both major political parties
Faced with anti-Israel and even anti-Jewish sentiment by party activists, and by an increasing number of political candidates, many Jewish voters are facing uncomfortable choices as they cast their ballots this year.
Price of San Diego: Rising cost of youth sports leaving some kids on the sideline
A recent study by the Aspen Institute’s Project Play shows that family spending on youth sports has increased by 46% since 2019. Making it out of reach for many low-income families.
Green Life Business Group brokers the cannabis industry’s biggest deals
Behind every many major cannabis transactions, you can find Green Life Business Group
AI in Mental Healthcare Presents Both Opportunities and Challenges
Artificial intelligence (AI) technology and its applications are reshaping many domains of modern life, including how individuals seek support for mental health needs and how they receive that care. Healthcare professionals are rapidly adopting AI-based applications designed to support workflow and care delivery, streamline processes, and help expand access to services.
U.S. Bank Survey Finds Gen Z Small Business Owners Are Making Bigger Bets to Drive Growth
Gen Z Momentum: Gen Z owners are nearly twice as likely as Gen X and Baby Boomer owners to make bigger bets on growth, while also reporting stronger business performance Growth Continues, But Less Widespread: Many small businesses are still expanding, though fewer are doing so as economic pressures persist AI Adoption Gap: Businesses adopting generative AI and digital tools are more likely to be in a growth phase U.S. Bank released its fourth annual Small Business Perspective survey report today, highlighting how small business owners are navigating a more constrained environment, and how a new generation is building businesses differently. The nationwide survey of 1,000 small business owners, including an oversample of 200 Gen Z owners, shows that while many small businesses are still expanding, fewer are growing than a year ago amid ongoing economic pressures and rising costs. U.S. small businesses are still seeking to grow, despite economic concerns. “Growth may not be as
Nico Schlotterbeck’s World Cup is over through injury
Germany defender Nico Schlotterbeck has been ruled out of the rest of the World Cup through injury, Sky Germany confirms. The Borussia Dortmund defender sustained an ankle injury during the first hal...
Jewish voters express growing isolation amid rising antisemitism in both major political parties
Faced with anti-Israel and even anti-Jewish sentiment by party activists, and by an increasing number of political candidates, many Jewish voters are facing uncomfortable choices as they cast their ballots this year.
Rising Healthcare Costs Leave Many Americans Less Secure
By Deanna Neff HealthDay ReporterMONDAY, June 22, 2026 (HealthDay News) — A growing number of Americans are finding themselves priced out of the healthcare system. Only 49% of U.S. adults report being “cost secure,” meaning they can pay for the medical visits and treatments they need. That leaves ...
Kansas City small businesses say World Cup is hurting sales. There's no bump like the city promised
Kansas City has welcomed thousands of visitors as the metro enters its second week of the World Cup. But as international crowds come in, many local shop owners feel they're taking a backseat. Some small businesses say the economic boost is not evenly distributed.
Did college football peak in the 1990s? The case for a golden age goes beyond nostalgia
Why do so many of us look back fondly at ’90s college football? Perhaps because the ’90s were the best time to watch college football on TV.
Work visa issues leave Door County businesses short staffed for summer season
Businesses say they are facing staffing challenges because many of the foreign workers they rely on through the summer tourism season haven’t arrived.
🌈 The conflictual politics of Pride events
Amid the rise of far-right and anti-gender movements, and given growing internal conflicts and divisions, many LGBTQAI+ people worry about the future of Pride events. But Francesca Romana Ammaturo reveals that throughout its history, Pride has reflected many different visions of activism and community
Business Meets to Discuss Intervention in Johannesburg Crisis
Business Leadership South Africa, a lobby group that counts many of the chief executive officers of the country’s biggest companies among its members, said it will meet this week to discuss support for Johannesburg, which is struggling to pay its bills.
Apple's first Ultras are coming: 20 new products in 2026–2027 according to Bloomberg
Apple's new CEO John Ternus will begin his tenure in September with a wave of new products that will bring Apple fans many exciting new releases. Well-known Bloomberg analyst Mark Gurman has listed the most important new products coming our way after the summer break, including the first ones potentially bearing the “Ultra” moniker.
Mental health partnership aims to give young doctors in training the self-care skills to cope with stress of the job
Becoming a doctor requires long hours, over many years, often with a lot of stress. A mental health program at CU Anschutz aims to give young doctors the
'House of the Dragon' Season 3, episode 1: Everyone that dies
The Battle of the Gullet has claimed many lives.
Zeiss Medical Technology Collaborates With Envision Health Technologies to Advance Glaucoma Care Using VR-Based Testing
JENA, Germany—Zeiss Medical Technology, a leader in medical optics and digital healthcare solutions, has announced a strategic collaboration with Envision Health Technologies, a digital eye health company founded by glaucoma surgeon Lama A. Al-Aswad, MD, MPH, CEO, to help advance glaucoma care through gamified virtual reality (VR) technology. The companies said this collaboration aims to firmly strengthen scientific and clinical credibility in VR-based visual function testing, supported by Zeiss’ long history of innovation in perimetry, and will bring together clinical expertise and software innovation to help advance clinically relevant, patient-centered technologies for modern glaucoma care.
Father’s Day brings attention to men’s health, self-care
As families celebrate fathers and father figures this weekend, experts say many men are still not prioritizing their own health.
The Long Arm of the Chinese Academy of Sciences
Far more than just a research institution, the Chinese Academy of Sciences is a key investor behind many of China’s leading technology companies.
Science Writer Takes Aim at Many Universes Theory
What these speculations point to is the way new findings have destroyed classical materialism. Materialism isn’t so much dying out as breaking up.
Cowboys 2026 roster rundown: LB Justin Barron
How many linebackers do you think the Cowboys are going to carry?
Growing Interest in Liver Wellness Leads Consumers to Explore PureHealth Research Liver Health Supplements
What does it actually mean to feel "off" after a heavy meal, a few too many late nights, or a season of indulgence? More often than not, the answer points back to the liver – and PureHealth Research is spotlighting growing consumer interest in liver wellness, highlighting how targeted nutritional support could play a role in maintaining healthy liver function and overall well-being.
10 Walmart Gadgets Under $50 That Are Actually Worth Buying
You can get high-quality security cameras, Bluetooth speakers, Nintendo Switch controllers, and many other tech gadgets for under $50 at Walmart.
Ukraine spy and attack drones now bringing supplies to soldiers
Ukraine's front lines with Russia has become so dangerous that it wants to use as many unmanned systems as it can, including drones to carry gear.
One common fat may fuel type 2 diabetes while another helps fight it
Not all fats affect your body the same way. Researchers found that palmitic acid, a saturated fat common in many foods, may contribute to insulin resistance and type 2 diabetes by triggering inflammation, toxic fat buildup, and cellular stress. In contrast, oleic acid—the heart-healthy fat abundant in olive oil—appears to help protect insulin function and may even counter some of the harmful effects of palmitic acid.